Navigation Links
Equatorial Guinea's [EG] Ministry of Health convenes in Washington, DC with GB Group Global and TNI Biotech (OTCBB:TNIB) to launch major innovative health solutions and improve pharmaceutical quality for its citizens
Date:4/8/2013

WASHINGTON, April 8, 2013 /PRNewswire/ -- EG Ministry of Health recently met with Dr. Gloria B. Herndon of GB Group Global in the nation's capital as part of Equatorial Guinea's efforts to drastically raise its standards of health care. These endeavors include building a pharmaceutical manufacturing facility in EG, implementing pharmaceutical quality control and policies, and exploring the release of a new treatment (Low Dose Naltrexone) against cancer and HIV/AIDS.

The purpose of the visit of Dr. Diosdado-Vicente Milang Nsue, the Delegate Minister of Health & Social Services and Dr. Consuelo Ondo Efua , the Director General of Drug Supply and Medical equipment, was to engage with organizations who through assistance, partnership and the sharing of best-practices could close medical knowledge gaps and help bring improved health care to Equatorial Guineans.

Among issues discussed, Minister Dr. Milang Nsue raised a problem rampant overseas: The need for affordable high quality medicines. "The devastating effects of substandard and counterfeit medicines in circulation lead to treatment failure, increased mortality and the development of drug resistance."

Dr. Milang stressed the fact that "...establishing in Equatorial Africa a pharmaceutical manufacturing facility with an analytical laboratory would be of paramount importance..." The proposed facility was part of conversations with TNI Biotech (OTCBB:TNIB), GB-Energie, GB-Pharma, Howard University and the United States Pharmacopeia representatives.

Dr. Ondo Efua said, "With the establishment of a drug manufacturing facility to treat the most current pathologies and a laboratory for drug quality control we could guarantee the safety and high quality of medicines either produced in EG or imported. We would have taken an important step to halt the traffic and commercialization of the counterfeit medicines that undermine the quality of the health services delivered to our population."

Further, as EG is concerned in the global struggle to combat the scourge of diseases such as HIV/AIDS and cancer, new developments regarding the therapy known as IRT-103 Low Dose Naltrexone were explained during the sessions.

Concluding the sessions, Dr. Herndon said she felt the exchanges had been productive and pleased that "...we (GB Group Global) were able to demonstrate our commitment to viable and sustainable solutions to the issues of the citizens well being and the growth of the nation."

www.gbenergie.com


'/>"/>
SOURCE GB Group Global
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. AUL says New York Judges Ruling Allows Big Abortion to Gamble with Young Girls Health
2. Dynamic Healthcare Services Announces David Erb as Director of Sales
3. Healthcare Coalitions Across the Nation Band Together to Ready for Disasters
4. Kentucky Health Cooperative To Partner With ProCare Rx For Pharmacy Benefit Management
5. Assurex Health Appoints Chief Financial Officer and Payer Market Executive to Manage Rapid Growth in Personalized Medicine
6. Armada Health Care Achieves Full URAC Accreditation
7. Kimberly-Clark Health Care Acquires Anesthesia Business from Life-Tech
8. Healthrageous Unveils Accountable Health The Missing Piece To Engage Consumers In Their Health And Achieve Accountable Care Goals
9. Healthcare Tech developers ENuke Software LLC proud to announce completion of eBroselowLutens Artemis in Dutch, German, Portugese and Spanish
10. Everyday Health Expands Solutions For Pharmaceutical Industry Marketers
11. Saint Francis Signs Agreement to Upgrade and Extend the Use of Streamline Healths(R) Solutions for Five More Years
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2017)... Holdings, Inc. (NYSE: HRC), will host its fiscal third quarter ... 2017, beginning at 7:30 a.m. (CDT) / 8:30 a.m. (EDT). ... in the conference call, dial (877) 304-8969 (domestic) or (631) ... minutes prior to the start to allow time to connect. ... Webcast: A simultaneous webcast of the call will ...
(Date:6/16/2017)... 2017 Datascope Corp. is voluntarily performing a worldwide field correction ... electrical test failure code.     ... PART NUMBER ... 0998-UC-0446HXX; 0998-UC-0479HXX 0998-00-3013-XX;  ... This field correction also applies ...
(Date:6/14/2017)... 2017  ivWatch LLC, a medical device company focused ... therapy, is pleased to announce it was the Bronze ... Supplies and Equipment at the 2017 Medical Design Excellence ... industry. The award was presented by Medical Device and ... in New York during MD&M ...
Breaking Medicine Technology:
(Date:6/27/2017)... ... June 27, 2017 , ... The Kelahan Agency, a ... to residents of southern New Hampshire, is teaming up with the New Horizons ... and homelessness in the region. , New Horizons for New Hampshire provides a ...
(Date:6/27/2017)... ... , ... Dr. Richard Amato, a respected periodontist in Monroe, CT, ... Implant Center of Connecticut. As part of the renovation, the cutting-edge practice added two ... to improve patient comfort while making it possible for Dr. Amato to provide even ...
(Date:6/27/2017)... ... 2017 , ... East Los Angeles dentist, Ramin Assili DDS , comments ... happens to a woman during pregnancy can have profound effects on a developing fetus, ... on a baby’s long-term health. This study, which was performed at the University of ...
(Date:6/26/2017)... California (PRWEB) , ... June 26, 2017 , ... ... of Male Fertility & Sexual Medicine Specialists, in collaboration with the Fertility Center ... for male fertility care: PESA (percutaneous epidydimal sperm aspiration) and TESA (percutaneous testicular ...
(Date:6/26/2017)... ... , ... LARKR™ , an innovative new smartphone app providing on-demand talk ... to join its online treatment platform. , Launching in just a few days, ... number of people in need nationwide, and to supplement their traditional practices. Joining this ...
Breaking Medicine News(10 mins):